DCIR Antibody, anti-human, FITC, REAfinity™ 130-105-031 from Miltenyi Biotec | Biocompare.com

Be the first to write a review!

Citations:

Supplier Page from
Miltenyi Biotec for
DCIR Antibody, anti-human, FITC, REAfinity™

The DCIR Antibody, anti-human, FITC, REAfinity™ from Miltenyi Biotec is a Human Monoclonal antibody to CLEC4A. This antibody recognizes Human antigen. The DCIR Antibody, anti-human, FITC, REAfinity™ has been validated for the following applications: Flow Cytometry.

Product Specs
ItemDCIR Antibody, anti-human, FITC, REAfinity™
CompanyMiltenyi Biotec
Price Pricing Info Supplier Page View Company Product Page
Catalog Number130-105-031
Quantity30 tests in 300 µL
ApplicationsFlow cytometry
Conjugate/TagFITC
FormatReagents are supplied in buffer containing stabilizer and 0.05% sodium azide
Reactivityhuman
TargetDCIR
IsotypeIgG1
CloneREA329
Hosthuman cell line
Antibody TypePrimary antibodies, Recombinant antibodies
Clonalitymonoclonal
Regulatory StatusFor research use only
Concentration1:11
ModificationsRecombinantly engineered
NCBI Full Gene NameC-type lectin domain family 4 member A
NCBI Gene AliasesCD367, CLECSF6, DCIR, DDB27, HDCGC13P, LLIR, hDCIR
Research AreaFor research use only

Add to Compare List

Miltenyi Biotec

Local Office

Miltenyi Biotec

Miltenyi Biotec Inc.

2303 Lindbergh Street

Auburn, CA 95602

United States

Phone: Phone: +1 530 888 8871
Toll Free: 800 FOR MACS
Fax: +1 530 888 8925

Email: macs@miltenyibiotec.com

Company Profile

Website: www.miltenyibiotec.com

International Office

Miltenyi Biotec

Miltenyi Biotec B.V. & Co. KG

Friedrich-Ebert-Straße 68

51429 Bergisch Gladbach

Germany

Phone: +49 2204 8306-0
Fax: +49 2204 8306-235

Email: macs@miltenyibiotec.de

Company Profile

Website: www.miltenyibiotec.com

(1) Ligand binding and signaling of dendritic cell immunoreceptor (DCIR) is modulated by the glycosylation of the carbohydrate recognition domainPloS oneJanuary 1, 2013Bloem K, Vuist IM, van der Plas AJ, Knippels LM, Garssen J, García-Vallejo JJ, van Vliet SJ, van Kooyk Y.

(2) The expression pattern of the ITIM-bearing lectin CLECSF6 in neutrophils suggests a key role in the control of inflammationJournal of leukocyte biologyMay 1, 2002Richard M, Veilleux P, Rouleau M, Paquin R, Beaulieu AD.

(3) APCs express DCIR, a novel C-type lectin surface receptor containing an immunoreceptor tyrosine-based inhibitory motifJournal of immunology (Baltimore, Md. : 1950)August 15, 1999Bates EE, Fournier N, Garcia E, Valladeau J, Durand I, Pin JJ, Zurawski SM, Patel S, Abrams JS, Lebecque S, et al.

Be the First to Write a Review!